Answers are grounded in this paper and cite their sources.
Background and objectives: Sepsis-related morbidity and mortality increase when appropriate empirical antibiotic therapy is not administered. Changes in antimicrobial susceptibility patterns reflect the emergence of multidrug-resistant organisms. These global concerns can be addressed through the judicious use of empirical antibiotics. Therefore, we conducted this study to determine the usage patterns of empirical antibiotics in patients with sepsis arising from various suspected sources of infection. Additionally, we examined the associations between empirical antibiotic use and the detected pathogens. Materials and methods: This cross-sectional study was conducted at Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India, from October 2025 to September 2026. We enrolled adult patients with sepsis admitted to the KIMS medical intensive care unit during the study period. We recorded Sequential Organ Failure Assessment (SOFA) scores and white blood cell (WBC) counts. The associations between empirical antibiotics and pathogenic bacteria were illustrated using alluvial plots. We analyzed the collected data by suspected source of infection (i.e., abdomen, central nervous system (CNS), respiratory system, skin and soft tissue, and urinary system). R software version 4.6.1 (R Core Team, Vienna, Austria) was employed for data analysis. Results: We analyzed data from 683 patients with sepsis (median age: 58.0 years; males: 384 (56.22%)). The median length of hospital stay was 17.0 (14.0-21.0) days. The most common suspected source of infection was the respiratory system (276, 40.41%), followed by the urinary system (191, 27.96%), abdomen (96, 14.06%), CNS (74, 10.83%), and skin and soft tissue (46, 6.73%). On day 0, the median SOFA scores of the participants with abdominal, CNS, respiratory, skin and soft tissue, and urinary infections were 5.0 (3.0-6.0), 4.0 (3.0-7.5), 5.0 (3.0-6.0), 5.0 (2.0-8.8), and 4.0 (3.0-6.0), respectively (p = 0.850). The corresponding WBC counts were 17.2 (14.8-19.3) × 10⁹/L, 16.3 (14.8-19.0) × 10⁹/L, 16.8 (14.6-19.2) × 10⁹/L, 16.3 (14.7-19.1) × 10⁹/L, and 17.1 (14.8-19.2) × 10⁹/L, respectively (p = 0.802). Regardless of the source of infection, beta-lactams were the mainstay of empirical antimicrobial therapy. Ceftriaxone, meropenem, and piperacillin-tazobactam were the most commonly used empirical antibiotics in our study population. The most common pathogenic bacteria detected among participants with abdominal, CNS, respiratory, skin and soft tissue, and urinary infections were Escherichia coli (25/96, 26.0%), Streptococcus pneumoniae (19/74, 25.7%), Klebsiella pneumoniae (92/276, 33.3%), Streptococcus pyogenes (12, 26.1%), and Escherichia coli (72, 37.7%), respectively. Most combination therapies remained unchanged following the culture and antimicrobial susceptibility testing results. Conclusions: Beta-lactams were the most commonly used class of antibiotics for empirical therapy in our study population. Respiratory and urinary infections were more common than other infections. Escherichia coli and Klebsiella pneumoniae were the most common pathogenic bacteria detected among participants.
No takes yet. Share an insight, caveat, or question.
Mohapatra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: